Traders Hedge as U.S. Vote Nears: Stock Market Braceby Terry Bingman 12.02.2024Investors are preparing for potential market turbulence surrounding the US presidential election, with demand for options increasing earlier than in ...
Gilead Acquires CymaBay: Liver Cure Leap?by Mark Eisenberg 12.02.2024Gilead Sciences acquires CymaBay Therapeutics for $4.3 billion to expand its liver disease portfolio, including access to potential treatment for ...
Bristol Myers Bags RayzeBio in $4.1B Cancer Fight Pactby Mark Eisenberg 12.02.2024Pharma giant Bristol Myers Squibb acquires RayzeBio for $4.1 billion, expanding its presence in the oncology sector and strengthening its ...